U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT06960655) titled 'Improving Lipid Optimization Quality and Treatment Options in ASCVD' on April 29.
Brief Summary: We are studying different approaches to improve the utilization of guideline directed medicines to lower cholesterol in patients with or at high risk of atherosclerosis (cholesterol buildup in the arteries).
Study Start Date: Aug. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Hypercholesterolemia
ASCVD
Intervention:
DRUG: statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran
Medication initiations and titrations are based on an established drug-treatment algorithm that utilizes a statutory-defined Collaborative Dru...